Total Payments
$32,737
2024 Payments
$127.42
Companies
17
Transactions
95
Medicare Patients
6,088
Medicare Billing
$400,792
Payment Breakdown by Category
Other$28,630 (87.5%)
Food & Beverage$3,130 (9.6%)
Consulting$468.00 (1.4%)
Travel$465.84 (1.4%)
Education$42.54 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,630 | 16 | 87.5% |
| Food and Beverage | $3,130 | 67 | 9.6% |
| Consulting Fee | $468.00 | 2 | 1.4% |
| Travel and Lodging | $465.84 | 8 | 1.4% |
| Education | $42.54 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23,497 | 34 | $0 (2020) |
| GlaxoSmithKline, LLC. | $7,865 | 28 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $268.12 | 17 | $0 (2024) |
| Insmed, Inc. | $126.66 | 2 | $0 (2019) |
| Amarin Pharma Inc. | $125.00 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $123.47 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $121.83 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $119.72 | 1 | $0 (2019) |
| Amgen Inc. | $115.81 | 1 | $0 (2018) |
| Inspire Medical Systems, Inc. | $103.38 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $127.42 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($68.77) |
| 2023 | $7,232 | 14 | GlaxoSmithKline, LLC. ($7,116) |
| 2022 | $457.23 | 14 | GlaxoSmithKline, LLC. ($295.66) |
| 2021 | $400.98 | 9 | GlaxoSmithKline, LLC. ($265.21) |
| 2020 | $2,735 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,610) |
| 2019 | $8,031 | 19 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,478) |
| 2018 | $7,296 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,114) |
| 2017 | $6,457 | 16 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,295) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $50.12 | General |
| Category: NEUROLOGY | ||||||
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/05/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $8.53 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/30/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $53.26 | General |
| Category: NEUROLOGY | ||||||
| 08/09/2023 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 07/25/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $121.80 | General |
| 05/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/09/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2023 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| 04/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/03/2023 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,625.00 | General |
| 03/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/23/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $121.81 | General |
| 02/06/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/10/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $121.81 | General |
| 10/18/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/25/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,372 | 1,630 | $216,751 | $88,231 |
| 2022 | 19 | 1,498 | 1,792 | $238,318 | $99,046 |
| 2021 | 19 | 1,523 | 1,829 | $246,984 | $108,278 |
| 2020 | 21 | 1,695 | 2,090 | $258,518 | $105,237 |
Total Patients
6,088
Total Services
7,341
Medicare Billing
$400,792
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 422 | $73,006 | $36,505 | 50.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 224 | 254 | $29,718 | $14,798 | 49.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $19,224 | $8,396 | 43.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 135 | 152 | $13,680 | $5,855 | 42.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 135 | 152 | $11,400 | $4,505 | 39.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 39 | 41 | $19,065 | $3,660 | 19.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $5,126 | $2,895 | 56.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 26 | 26 | $11,258 | $2,183 | 19.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 65 | 73 | $8,979 | $1,882 | 21.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $4,176 | $1,847 | 44.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 79 | 87 | $6,177 | $1,604 | 26.0% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 39 | 39 | $4,680 | $1,268 | 27.1% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 74 | 77 | $2,695 | $964.72 | 35.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 77 | 91 | $819.00 | $764.40 | 93.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 12 | 12 | $4,200 | $517.84 | 12.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 39 | 42 | $1,260 | $319.62 | 25.4% |
| 82565 | Blood creatinine level | Office | 2023 | 28 | 30 | $630.00 | $150.60 | 23.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 14 | 14 | $658.00 | $116.06 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 293 | 480 | $83,040 | $42,372 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 217 | 248 | $29,016 | $15,039 | 51.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 99 | 99 | $26,433 | $11,884 | 45.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 143 | 156 | $14,040 | $6,441 | 45.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 141 | 154 | $11,550 | $4,703 | 40.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 39 | 39 | $18,135 | $3,640 | 20.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 35 | 36 | $15,588 | $3,157 | 20.3% |
About Dr. Robert Hinkle, MD
Dr. Robert Hinkle, MD is a Pulmonary Disease healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023032422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hinkle, MD has received a total of $32,737 in payments from pharmaceutical and medical device companies, with $127.42 received in 2024. These payments were reported across 95 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($28,630).
As a Medicare-enrolled provider, Hinkle has provided services to 6,088 Medicare beneficiaries, totaling 7,341 services with total Medicare billing of $400,792. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Baton Rouge, LA
- Active Since 07/27/2006
- Last Updated 02/04/2011
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1023032422
Products in Payments
- TRELEGY ELLIPTA (Drug) $424.80
- ENTYVIO (Biological) $268.12
- NUCALA (Biological) $232.81
- Arikayce (Drug) $126.66
- Vascepa (Drug) $125.00
- FASENRA (Drug) $123.47
- DUPIXENT (Biological) $121.83
- INVOKANA (Drug) $119.72
- Repatha (Biological) $115.81
- INSPIRE (Device) $103.38
- Da Vinci Surgical System (Device) $84.42
- Monarch Platform (Device) $76.11
- Esbriet (Biological) $38.00
- OFEV (Drug) $33.97
- SUNOSI (Drug) $27.35
- DUPIXENT (Drug) $20.80
- Utibron (Drug) $14.67
- ANORO (Drug) $10.44
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $8.53
- BREO (Drug) $7.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Baton Rouge
Dr. Alexander Mulamula, M.d, M.D
Pulmonary Disease — Payments: $9,086
Pulmonary Disease $9,086
Vincent Valentine, Md, MD
Pulmonary Disease — Payments: $6,427
Pulmonary Disease $6,427
Mostafa Aboubakr, Md, MD
Pulmonary Disease — Payments: $4,838
Pulmonary Disease $4,838
Stephen Brierre, Md, MD
Pulmonary Disease — Payments: $2,385
Pulmonary Disease $2,385
Jonathan Richards, Md, MD
Pulmonary Disease — Payments: $2,365
Pulmonary Disease $2,365
Dr. Stuart Lebas, M.d, M.D
Pulmonary Disease — Payments: $1,829
Pulmonary Disease $1,829